<i>Pediococcus acidilactici</i> (pA1c®) alleviates obesity-related dyslipidemia and inflammation in Wistar rats by activating beta-oxidation and modulating the gut microbiota
Deyan Yavorov-Dayliev, Fermı́n I. Milagro, Miguel Lópeź‐Yoldi, Iñigo Clemente, José Ignacio Riezu‐Boj, Josune Ayo, María Oneca, Paula Aranaz
Abstract
genus. Thus, our data suggest the potential of pA1c® in the prevention of obesity-related disturbances including hypercholesterolemia, hypertriglyceridemia, inflammation and gut microbiota dysbiosis.
Topics & Concepts
Adipose tissueGut floraEndocrinologyInternal medicineDyslipidemiaBiologyTriglycerideInflammationCholesterolObesityBiochemistryMedicineDiet and metabolism studiesGut microbiota and healthAdipokines, Inflammation, and Metabolic Diseases